SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Tatva Chintan Pharma Chem informs about press release

08 Sep 2021 Evaluate
Tatva Chintan Pharma Chem has informed that it enclosed the copies of newspaper advertisement published in Financial Express (English) and Vadodara Samachar (Gujarati) on 8th September 2021, intimating e-voting information with respect to 25th Annual General Meeting of the Company that will held on 29th September 2021 at 4:00 p.m. (IST) through Video Conferencing (VC)/ Other Audio Visual Means (OAVM).

The above information is a part of company’s filings submitted to BSE.

Tatva Chintan Pharma Share Price

1275.10 -8.55 (-0.67%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3703.10
Tata Chemicals 709.05
SRF 2493.65
Pidilite Inds. 1393.25
Deepak Nitrite 1538.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×